What the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.13%Below 5Y avg (0.58%)
Annual Rate
CNY 0.08Paid semi-annual
Payout Ratio
80.0%Moderate
Last Ex-Dividend
Jun 9, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
7.47BCNY
1.12B · vs all stocks (USD)
Updated Oct 21, 2026
Revenue (TTM)
471.08MCNY
70.61M · vs all stocks (USD)
Updated Oct 21, 2026
Profit Margin
1.30%
vs Medical Instruments & Supplies peers
Updated Oct 21, 2026
Beta
0.8030x
vs all stocks
Updated Oct 21, 2026
52-Week Change
127.29%
vs all stocks
Updated Oct 21, 2026
Forward Annual Dividend Yield
0.13%
vs all stocks
Updated Oct 21, 2026
Market Capitalization
7.47BCNY
1.12B · vs all stocks (USD)
Updated Oct 21, 2026
Enterprise Value
7.41BCNY
1.11B · vs all stocks (USD)
Updated Oct 21, 2026
Forward P/E
68.70x
vs Medical Instruments & Supplies peers
Updated Oct 21, 2026
Price to Sales (TTM)
16.67x
vs Medical Instruments & Supplies peers
Provider-reported. Market Capitalization ÷ Revenue (TTM) on this page gives 15.87×.Updated Oct 21, 2026
Price to Book (MRQ)
4.15x
vs Medical Instruments & Supplies peers
Updated Oct 21, 2026
Enterprise to Revenue
15.72x
vs Medical Instruments & Supplies peers
Updated Oct 21, 2026
Enterprise to EBITDA
124.04x
vs Medical Instruments & Supplies peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 104.73×.Updated Oct 21, 2026
Gross Margin
21.31%
vs Medical Instruments & Supplies peers
Updated Oct 21, 2026
Profit Margin
1.30%
vs Medical Instruments & Supplies peers
Updated Oct 21, 2026
Operating Margin
-6.52%
vs Medical Instruments & Supplies peers
Updated Oct 21, 2026
Return on Assets (TTM)
-0.01%
vs Medical Instruments & Supplies peers
Updated Oct 21, 2026
Return on Equity (TTM)
0.11%
vs Medical Instruments & Supplies peers
Updated Oct 21, 2026
Revenue (TTM)
471.08MCNY
70.61M · vs all stocks (USD)
Updated Oct 21, 2026
Revenue per Share (TTM)
4.07CNYUpdated Oct 21, 2026
Quarterly Revenue Growth
53.40%
vs Medical Instruments & Supplies peers
Updated Oct 21, 2026
Gross Profit (TTM)
98.22MCNY
14.72M · vs all stocks (USD)
Updated Oct 21, 2026
EBITDA (TTM)
70.72MCNY
10.60M · vs all stocks (USD)
Updated Oct 21, 2026
Net Income (TTM)
6.14MCNY
920.38K · vs all stocks (USD)
Updated Oct 21, 2026
Quarterly Earnings Growth (YoY)
80.75%
vs Medical Instruments & Supplies peers
Updated Oct 21, 2026
Operating Cash Flow (TTM)
17.86MCNY
2.68M · vs all stocks (USD)
Updated Oct 21, 2026
Levered Free Cash Flow (TTM)
-175.79MCNY
-26.35M · vs all stocks (USD)
Updated Oct 21, 2026
Forward Annual Dividend Rate
0.0800CNYUpdated Oct 21, 2026
Forward Annual Dividend Yield
0.13%
vs all stocks
Updated Oct 21, 2026
Trailing Annual Dividend Rate
0.2900CNYUpdated Oct 21, 2026
Trailing Annual Dividend Yield
0.47%
vs all stocks
Updated Oct 21, 2026
5-Year Average Dividend Yield
0.58%
vs all stocks
Updated Oct 21, 2026
Payout Ratio
80.00%
vs Medical Instruments & Supplies peers
Provider-reported. Trailing Annual Dividend Rate ÷ Diluted EPS (TTM) on this page gives 580%.Updated Oct 21, 2026
Minority Interest (Equity)
4.98MCNYFY2025 · Dec 31, 2025
Revenue
356.69MCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
276.93MCNYFY2025 · Dec 31, 2025
Gross Profit
79.76MCNYFY2025 · Dec 31, 2025
Operating Income
3.22MCNY
482.30K · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
1.34MCNYFY2025 · Dec 31, 2025
Income Tax Expense
-1.22MCNYFY2025 · Dec 31, 2025
Net Income
2.55MCNYFY2025 · Dec 31, 2025
EBIT
1.80MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
70.72MCNYFY2025 · Dec 31, 2025
Research & Development
21.96MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
19.25MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
5.55MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
4.03MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
463.50KCNYFY2025 · Dec 31, 2025
EPS (Basic)
0.0500CNYFY2025 · Dec 31, 2025
EPS (Diluted)
0.0500CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
112.41MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
112.41MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
2.55MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
3.07MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
-61.44MCNYFY2025 · Dec 31, 2025
Free Cash Flow
-152.61MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
371.03MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
2.55MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
2.57MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-34.13MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-32.44MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-91.17MCNYFY2025 · Dec 31, 2025
Purchase of Investments
-2.52BCNYFY2025 · Dec 31, 2025
Sale of Investments
2.66BCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
51.53MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-30.56MCNYFY2025 · Dec 31, 2025
Other Financing Charges
1.06MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-29.50MCNYFY2025 · Dec 31, 2025
Shares Outstanding
122.25MSharesUpdated Oct 21, 2026
Float Shares
32.00MSharesUpdated Oct 21, 2026
% Held by Insiders
67.76%
vs all stocks
Updated Oct 21, 2026
% Held by Institutions
4.56%
vs all stocks
Updated Oct 21, 2026
Total Cash (MRQ)
760.93MCNY
114.06M · vs all stocks (USD)
Updated Oct 21, 2026
Total Cash per Share (MRQ)
6.22CNYUpdated Oct 21, 2026
Total Debt (MRQ)
168.36MCNY
25.24M · vs all stocks (USD)
Updated Oct 21, 2026
Total Debt to Equity (MRQ)
0.0884x
vs Medical Instruments & Supplies peers
Updated Oct 21, 2026
Current Ratio (MRQ)
3.83x
vs Medical Instruments & Supplies peers
Updated Oct 21, 2026
Book Value per Share (MRQ)
15.48CNYUpdated Oct 21, 2026
Total Assets
2.01BCNY
300.67M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
1.02BCNYFY2025 · Dec 31, 2025
Total Liabilities
161.97MCNYFY2025 · Dec 31, 2025
Total Non-current Assets
989.76MCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
42.62MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
119.35MCNYFY2025 · Dec 31, 2025
Cash
371.03MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
371.03MCNYFY2025 · Dec 31, 2025
Other Short-term Investments
435.11MCNYFY2025 · Dec 31, 2025
Accounts Receivable
90.26MCNYFY2025 · Dec 31, 2025
Inventory
100.67MCNYFY2025 · Dec 31, 2025
Accounts Payable
91.44MCNYFY2025 · Dec 31, 2025
Short-term Debt
3.50MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
84.33KCNYFY2025 · Dec 31, 2025
Long-term Debt
27.92MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
122.25MCNYFY2025 · Dec 31, 2025
Retained Earnings
452.19MCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
1.84BCNY
276.39M · vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
23.00CNYUpdated Oct 21, 2026
52-Week High
71.74CNYUpdated Oct 21, 2026
52-Week Change
127.29%
vs all stocks
Updated Oct 21, 2026
Beta
0.8030x
vs all stocks
Updated Oct 21, 2026
50-Day MA
51.18CNYUpdated Oct 21, 2026
200-Day MA
35.29CNYUpdated Oct 21, 2026
Avg 10-Day Volume
5.72MSharesUpdated Oct 21, 2026
Avg 30-Day Volume
6.27MSharesUpdated Oct 21, 2026
Diluted EPS (TTM)
0.0500CNYUpdated Oct 21, 2026
3 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
It can cover near-term bills from cash alone, not just from inventory.
Reads
Low-Leverage Liquidity Configuration
Cash on hand covers most or all of its debt, and its equity share of assets is high for its industry.
Reads
How does this company use capital?
Minimal Tax and Interest Drag
Almost nothing is lost between its operating profit and its net income.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Companies that share the same coordination system — how they create, deliver, or capture value.